Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold J Burstein

Showing results (21-30 of 251) with videos related to

Pageof 26
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2012
JNCCN reaches 10Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Disclosing pharma payments to oncologists: what will we learn?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
What is a patient navigator, and should we have them in major cancer centers?Harold J Burstein
The New England Journal of Medicine|November 27, 2024
Immunotherapy for Early-Stage Triple-Negative Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Off-label use of oncology drugs: too much, too little, or just right?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Keeping cancer patients out of the hospital at the end of lifeHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Lou Gehrig, Angelina Jolie, and cancer geneticsHarold J Burstein
Breast (Edinburgh, Scotland)|October 1, 2013
Patients with triple negative breast cancer: is there an optimal adjuvant treatment?Harold J Burstein
Hematology/Oncology Clinics of North America|November 26, 2022
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Assuring access to academic cancer centersHarold J Burstein
Pageof 26

Showing results (21-30 of 251) with videos related to

Sort By:
Pageof 26
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2012
JNCCN reaches 10Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Disclosing pharma payments to oncologists: what will we learn?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
What is a patient navigator, and should we have them in major cancer centers?Harold J Burstein
The New England Journal of Medicine|November 27, 2024
Immunotherapy for Early-Stage Triple-Negative Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Off-label use of oncology drugs: too much, too little, or just right?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Keeping cancer patients out of the hospital at the end of lifeHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Lou Gehrig, Angelina Jolie, and cancer geneticsHarold J Burstein
Breast (Edinburgh, Scotland)|October 1, 2013
Patients with triple negative breast cancer: is there an optimal adjuvant treatment?Harold J Burstein
Hematology/Oncology Clinics of North America|November 26, 2022
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Assuring access to academic cancer centersHarold J Burstein
Pageof 26